Bibliography: Prevalence

Quarterly data are published on StatsWales. These include data on quarterly activity, case closures by reason for closure and the time between referral and start of treatment (Welsh Government)

Data from the National Vital Statistics System, Mortality (CDC)

Mortality statistics on deaths registered in England and Wales by age-group, sex and underlying cause of death (National Statistics, UK)

Analysis of drug-related deaths and suicides in England and Wales, 2008 to 2016 (Office for National Statistics, UK)

Each year, the Australian Bureau of Statistics (ABS) makes available to Drug Trends in-depth data on drug-induced deaths in Australia. This year, we have produced a suite of products to summarise trends in drug-induced deaths in Australia from 1997 to 2017 (NDARC)

In this article, NDARC’s Dr Rachel Sutherland provides an in-depth overview of new psychoactive substances (NPS) in Australia that covers what they are, who uses them and which specific NPS are being consumed (NDARC)

The Australian Criminal Intelligence Commission has commissioned the University of Queensland, and through it the University of South Australia, to undertake the data collection and analysis that underpins the report. This is the seventh in a series of nine public reports

Report from the ACMD providing advice to the government on the changing age profile of people accessing drug treatment and the challenges faced by this cohort in the UK

We collate information here about the reported effects of new psychoactive substances (NPS) and other drugs. Information comes from a range of intelligence sources (including RIDR) to support frontline practitioners, service providers and other stakeholders in responding to new and emerging health harms (Public Health England)

In response to recent reports of increasing harms related to methamphetamine use in Canada, this bulletin summarizes recent changes in stimulant-related harms in Canadian communities (CCSA)